References
- PasinEJosephsonDYMitraAPCoteRJSteinJPSuperficial bladder cancer: an update on etiology, molecular development, classification, and natural historyRev Urol2008101314318470273
- SuCCSuJHLinJJAn investigation into the cytotoxic effects of 13-acetoxysarcocrassolide from the soft coral Sarcophyton crassocaule on bladder cancer cellsMar Drugs20119122622264222363243
- BurgerMCattoJWDalbagniGEpidemiology and risk factors of urothelial bladder cancerEur Urol201363223424122877502
- SerontEMachielsJPMolecular biology and targeted therapies for urothelial carcinomaCancer Treat Rev201541434135325828962
- von der MaaseHHansenSWRobertsJTGemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III studyJ Clin Oncol200018173068307711001674
- RobertsJTvon der MaaseHSengelovLLong-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancerAnn Oncol200617suppl 5v118v12216807438
- LoehrerPJSrEinhornLHElsonPJA randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group studyJ Clin Oncol1992107106610731607913
- SternbergCNYagodaAScherHIMethotrexate, vinblastine, dox-orubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseCancer19896412244824582819654
- SuTRLinJJChiuCCProteomic investigation of anti-tumor activities exerted by sinularin against A2058 melanoma cellsElectrophoresis20123371139115222539317
- ChenYJSuJHTsaoCYSinulariolide induced hepatocellular carcinoma apoptosis through activation of mitochondrial-related apoptotic and PERK/eIF2alpha/ATF4/CHOP pathwayMolecules2013189101461016123973991
- LedroitVDebitusCAusseilFRauxRMenouJ-LHillBHeteronemin as a protein farnesyl transferase inhibitorPharm Biol2004426454456
- ChangYCTsengSWLiuLLCytotoxic sesterterpenoids from a sponge Hippospongia spMar Drugs201210598799722822351
- SchumacherMCerellaCEifesSHeteronemin, a spongean sesterterpene, inhibits TNF alpha-induced NF-kappa B activation through proteasome inhibition and induces apoptotic cell deathBiochem Pharmacol201079461062219814997
- MahapatroASinghDKBiodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccinesJ Nano-biotechnology2011955
- EgusquiaguirreSPIgartuaMHernandezRMPedrazJLNanoparticle delivery systems for cancer therapy: advances in clinical and preclinical researchClin Transl Oncol2012142839322301396
- SunQTeongBChenIFChangSJGaoJKuoSMEnhanced apoptotic effects of dihydroartemisinin-aggregated gelatin and hyaluronan nanoparticles on human lung cancer cellsJ Biomed Mater Res B Appl Biomater2014102345546224039154
- TeongBLinCYChangSJEnhanced anti-cancer activity by curcumin-loaded hydrogel nanoparticle derived aggregates on A549 lung adenocarcinoma cellsJ Mater Sci Mater Med2015261535725595721
- SiddiquiMAAlhadlaqHAAhmadJAl-KhedhairyAAMusarratJAhamedMCopper oxide nanoparticles induced mitochondria mediated apoptosis in human hepatocarcinoma cellsPLoS One201388e6953423940521
- LanMYHsuYBHsuCHHoCYLinJCLeeSWInduction of apoptosis by high-dose gold nanoparticles in nasopharyngeal carcinoma cellsAuris Nasus Larynx201340656356823722198
- ChoiKYSaravanakumarGParkJHParkKHyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancerColloids Surf B Biointerfaces201299829422079699
- BilensoyECationic nanoparticles for cancer therapyExpert Opin Drug Deliv20107779580920446858
- PrestwichGDMarecakDMMarecekJFVercruysseKPZiebellMRControlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivativesJ Control Release1998531–3931039741917
- VivekRThangamRNipunbabuVPonrajTKannanSOxaliplatin-chitosan nanoparticles induced intrinsic apoptotic signaling pathway: a “smart” drug delivery system to breast cancer cell therapyInt J Biol Macromol20146528929724472507
- LiaoMHLiuSSPengICTsaiFJHuangHHThe stimulatory effects of alpha1-adrenergic receptors on TGF-beta1, IGF-1 and hyaluronan production in human skin fibroblastsCell Tissue Res2014357368169324844469
- SalidoMGonzalezJLVilchesJLoss of mitochondrial membrane potential is inhibited by bombesin in etoposide-induced apoptosis in PC-3 prostate carcinoma cellsMolecular Cancer Therapeutics2007641292129917431107
- BhattacharyaSAhirMPatraPPEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34aBiomaterials2015519110725771001
- YangJAPhanHTVaidyaSMurphyCJNanovacuums: nanoparticle uptake and differential cellular migration on a carpet of nanoparticlesNano Lett20131352295230223577660
- MoennerMPluquetOBouchecareilhMChevetEIntegrated endoplasmic reticulum stress responses in cancerCancer Res20076722106311063418006802
- VerfaillieTGargADAgostinisPTargeting ER stress induced apoptosis and inflammation in cancerCancer Lett2013332224926420732741
- YangJWeiJWuYMetformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancerOncogenesis20154e15826075749
- HillaireauHCouvreurPNanocarriers’ entry into the cell: relevance to drug deliveryCell Mol Life Sci200966172873289619499185
- SnipstadSWestromSMorchYAfadziMAslundAKde Lange DaviesCContact-mediated intracellular delivery of hydrophobic drugs from polymeric nanoparticlesCancer Nanotechnol201451825774230
- HuangHHBrennanTCMuirMMMasonRSFunctional alpha1- and beta2-adrenergic receptors in human osteoblastsJ Cell Physiol2009220126727519334040